Rally is proud to be the initial funder for the creation of the INSTRuCT Database with a Consortium Grant to Dr. Sam Volchenboum of the...
INSTRuCT Database for Rhabdomyosarcoma Impact
read more
Rally Researchers
New RNA Therapies for Glioblastoma from Small Phase 1 Study
Glioblastoma (GBM) in children and adults is a deadly brain tumor with a poor prognosis. Current treatment includes surgery to remove as...
What is Big Data and Childhood Cancer Research
After being born and living in Turkey my whole life, I came to the US for college to study biological sciences at the University of...
The Spark Has Ignited A Fire: How Rally’s Seed Funding Paved the Way for Dr. Volchenboum and the PCDC
At Rally Foundation for Childhood Cancer Research, we often describe ourselves as “philanthropic seed investors in the next great...
The New England Journal of Medicine
Chills ran up and down my arms when I opened the link that Rally-funded researcher Dr. Gregory Friedman sent. I was staring at the New...
Rally Foundation Announces Young Investigator Recipients of its Largest-Ever Grant Awards
We are living in unprecedented times. As the world grapples with a number of issues, including the COVID-19 pandemic, nothing seems normal...
How Rally’s Grant Helped Rally Researcher Dr. Michael Kinnaman: Part 2
Rally Researcher, Medical Advisory Board member and pediatric oncologist Dr. Michael Kinnaman is the recipient of Rally’s Postdoctoral and...
Why I Chose Pediatric Oncology and Research
Rally Researcher and pediatric oncologist Dr. Michael Kinnaman received a Rally Postdoctoral and Clinical Research Fellow Grant. In part...
$3.3 Million of Good News
Could you use some good news? We have some good news. Actually, we have some GREAT news! Rally Foundation for Childhood Cancer Research...
Newly Elected COG Chair Dr. Douglas Hawkins Shares His ‘North Star’
Rally was pleased when it was announced that the newly elected chair of the Children’s Oncology Group (COG) was going to be Dr. Doug...
Research for Recurrent Brain Tumors Shows Promising Preliminary Results
As a Rally Researcher and the primary investigator at the University of Alabama at Birmingham, Gregory Friedman, M.D. is devoted to...
Rally Foundation for Childhood Cancer Research Announces $3 Million in Grant Awards
In the United States, cancer is the number one disease killer of children. Yet pediatric cancer isn’t exclusive to America; it’s a global epidemic that affects more than 300,000 children around the world.
New Developments in Osteosarcoma Therapies
In the United States, cancer is the number one disease killer of children. Yet pediatric cancer isn’t exclusive to America; it’s a global epidemic that affects more than 300,000 children around the world.
International Childhood Cancer Day
In the United States, cancer is the number one disease killer of children. Yet pediatric cancer isn’t exclusive to America; it’s a global epidemic that affects more than 300,000 children around the world.
Rally Researchers
Rally Foundation Awards $5.5M for a Record Number of Grants to 75 Childhood Cancer Researchers
In 2025, Rally Foundation for Childhood Cancer Research (Rally) is thrilled to award a total of $5.5 million in childhood cancer research grants to 75 researchers across 40 institutions worldwide. This is the foundation’s largest award value to be distributed since its founding in 2005. Rally proudly funds the best and the brightest researchers, seeking the most innovative and promising research. This year’s awards include 75 grants given to 8 Consortiums, 23 Independent Investigators, 13...
Rally Foundation Awards $5M for a Record Number of Grants to 74 Childhood Cancer Researchers
Rally Foundation for Childhood Cancer Research Awards $5M in 2024 In 2024, Rally Foundation for Childhood Cancer Research (Rally) will award a total of $5 million to 74 researchers across 34 institutions worldwide – the largest number of childhood cancer research grants ever to be distributed since Rally was founded in 2005. “This brings the total amount of research funds that Rally has awarded to $35 million – and it is the highest amount we have been able to award in one year,” says Dean...
Rally Awards Outside the Box Grants
Rally Awards Novel Grants to Three Childhood Cancer Researchers Rally Foundation for Childhood Cancer Research (“Rally”) awarded $150,000 to three researchers at three different institutions for Outside the Box novel childhood cancer research ideas. “Rally sees itself as philanthropic seed investors in the next great discovery — we like to invest early and are willing to take risks because these Outside the Box ideas may pave the way to finding better treatments and cures,” says Dean Crowe,...
Rally Awards Most Grants Ever
Rally Foundation for Childhood Cancer Research Awards $4 Million in 2023 In 2023, Rally Foundation for Childhood Cancer Research (“Rally”) will award a total of $4 million to 57 researchers across 30 institutions worldwide – the largest number of childhood cancer research grants ever to be distributed since Rally was founded in 2005. “This brings the total amount of research funds that Rally has awarded to $29.4 million – and it is the highest amount we have been able to award in one year,”...
Durbin Keeps Asking New Questions
Passion for Pediatric Cancer Patients and Research Drives Meaningful Discovery “Every day, I’m motivated to discover more through research that will enable us to better treat children with cancer and improve outcomes with fewer side effects.” Since his first lab job in the summer between his freshman and sophomore year in college, Adam D. Durbin, MD, PhD, of the Division of Molecular Oncology, Department of Oncology, St. Jude Children’s Research Hospital, has been fascinated by medical...
One Mission, 51 Childhood Cancer Researchers, $3.4 Million in Grants
Rally Foundation for Childhood Cancer Research Awards $3.4 Million in Grants This year, 51 researchers from 31 institutions across the country and worldwide will receive a total of $3.4 million in grants from Rally Foundation for Childhood Cancer Research. “Rally Foundation has now awarded $25.4 million in grants for childhood cancer research since we started in 2005,” says Dean Crowe, Founder and CEO. “From the beginning, our mission has been to fund the best research wherever it may be to...